The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models

Cardiovascular disease is a major cause of death globally. This has led to significant efforts to develop new anti-thrombotic therapies or re-purpose existing drugs to treat cardiovascular diseases. Due to difficulties of obtaining healthy human blood vessel tissues to recreate in vivo conditions, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Njoroge, Wanjiku, Hernández, Andrea C. Hernández, Musa, Faiza Idris, Butler, Robert, Harper, Alan G. S., Yang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998107/
https://www.ncbi.nlm.nih.gov/pubmed/33807995
http://dx.doi.org/10.3390/pharmaceutics13030340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998107/
https://www.ncbi.nlm.nih.gov/pubmed/33807995
http://dx.doi.org/10.3390/pharmaceutics13030340

Ejemplares similares